We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Reliance Gen. | LSE:GMX | London | Ordinary Share | GB00B1MM9925 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.55 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
18/4/2004 19:18 | About to start the climb. This is looking at about 100% upwards in the short term. Products to come onto the market shortly - from a tip! | peterleonard | |
15/4/2004 15:20 | handycam - looks like GMX were able to raise £1.9 million via an institutional placing in the Far East. As of today's announcement I am rating them a buy for the following reasons: 1. They will have enough cash to see them through the launch of two significant new products 2. They intend to list on the NYSE 3. They are still in partnership talks 4. They now have time to collect the cash owing to them 5. The placing was not at a substantial discount to current share price As always DYOR etc. AMARONE. | amarone | |
01/4/2004 12:42 | Q: How much cash does GMX have left as at this date? A: None. Q.: Why do they have to scout around looking for cash? A: Because the banks won't lend them any. Q. And why won't the banks lend cash? A. Because they'll never see it again. Work it out for yourselves. | handycam | |
12/3/2004 13:11 | While we wait for developments, a snippet on China: In the ten years from 1989 to 1999 the value of the pharmaceutical market in China has risen from $2.4 billion to $11 billion. It is forecast to grow to $35 billion by 2010. China is a member of the World Trade Organisation and respects patents – companies such as Amgen, AstraZeneca, Aventis, BMS, Bayer, Boehringer Ingelheim, Johnson & Johnson, Merck, Novartis, Pfizer, Roche and many more are prepared to invest in this huge country. | nil pd | |
10/3/2004 21:52 | MM's sneaked a 25,000 buy in at 16.47pm! Naughty, naughty ! AMARONE. | amarone | |
10/3/2004 16:28 | Looking good! | nil pd | |
10/3/2004 16:27 | GMX comes good again! AMARONE. | amarone | |
10/3/2004 09:01 | Clearly the market has decided not to take it any lower than this prior to the announcement. I'm coming around to the opinion of a higher valuation too, like yours Peter, though sooner. Based on a feeling of who the other party is. | nil pd | |
09/3/2004 21:49 | News will soon follow and I can't see this company fail, the potential for GMX is such that will need financial help as with many similar drugs producers. There is a tendency of collaboration with big fish and I feel this will soon be the case. DYOR Looking/hoping at 45p May/June | peterleonard | |
09/3/2004 17:31 | Hi Nil Pd - thought everyone had bailed out! Seems an interesting proposition my friend, GMX even made it on to the ADVFN Top Risers Board! I guess like everything only time will tell. However, I'm still taking my lead from SGX - whatever happens over here. IMHO. AMARONE | amarone | |
09/3/2004 16:49 | Still here. I noticed that too, Amarone - only one up today in my whole portfolio. If GMX.Singapore is up again tonight we could be soon looking at the news we have been waiting for. | nil pd | |
09/3/2004 16:46 | Is anyone left on this thread? If you are, you are probably looking at one of the few small cap shares that went up today. Now who would of thought that, eh? AMARONE. | amarone | |
08/3/2004 10:11 | Hi Captain Spock, I agree that this stock is not for the faint hearted - but we are talking high risk high reward a element that should make up a part in everyones portfolio! I have made good returns in the last three weeks although I would say early on it was luck more than judgement. Now however, I intend to hold this stock until at April/may and see how things play out. The merger/takeover, the listing on the NYSE, the income revenue generated but not yet received etc, it WILL be a rollercoaster ride but one I firmly beleive will end with a high! My target price for GMX short term is 25p based upon positive news flow after that who knows. I keep remembering the dotcom days and the similarities with BioTech ie. great products / high cash burn = will they survive? I can't say for sure that they will so any potential investor would be better off buying little AND often that way you might not come off the rollercoaster and throw up! IMHO etc. AMARONE. | amarone | |
07/3/2004 13:07 | Comment...... This must be the most volatile & uncertain rollercoaster ride on the market at the moment & definitely should only be bought on a long term basis for those interested in making any serious money here ??? One for the very very brave IMHO, until at least some significant positive news is announced. Call it sour grapes if you like, but I've already lost £3.5k on this one by foolishly following the sheep a bit late on a T10- thought I'd learn't enough about trading shares not to be sucked into stocks like these, but obviously not !! However, may I wish good luck to all those still in for the longer term. Anyone care to add to my comments ? | captainspock | |
05/3/2004 10:44 | Jupiter now hold over 1%. Regards Tt. | truckertee | |
04/3/2004 16:52 | Thanks for all the info guys, will watch closely over the next two weeks. Looking at the chart action I would say today's looks like an intermediate top? Seems to be support around 13p so think i will wait and watch for a bit. May dip my toe in the water if the price comes back to 13p and starts to look oversold. Of course I may miss the boat all together.... downside risk sounds high and too much uncertainty to sustain the rally at the mo i think IMHO. Luck to all. | icetrader | |
04/3/2004 13:54 | AMARONE: been away from the boards. My view is that conclusion of a deal is imminent. Usually someone gets a sniff of these things from one or two individuals sharing confidential information with their close confidentes. This together with speculation has determined that recent prices were simply far too cheap. The company has stated that it is in discussions and, as I mentioned a few days back, it is incumbent on the company to close this deal quickly to avoid further market uncertainty - and of course to seal a safe future for the business. The deal will have to be satisfactory and therefore will revalue the shares considerably. By exactly how much is impossible to guess at this point but I feel we are looking at adding at least 10p to the price from here. Depends on the deal (cash/shares/both?). If it is not satisfactory, I reiterate my view that major pharma are desperate for pipeline and revenue and have pressure from both common business sense and shareholders to act. There are, IMO, companies waiting to pick up GMX if current discussions fail. If there is any mention of raising funds from shareholders it will be a tactic to close the deal at a higher price and fundraising will not materialise. As an avid pharma watcher my view is it should be good for both GMX and the other side. As you know I have an interest and at a higher price (failed to apply a stop loss). But I see an exciting few days ahead and do not anticipate closing this at a loss. Knowing that you have a keen eye for this sector, I expect none of the above to surprise you. To any reader of this, all the above is IMHO. Please DYOR. | nil pd | |
04/3/2004 10:37 | I agree with you pariah, speaking to the ceo on Monday he told me that there would alot of news coming out starting in about 2 weeks time, he was confident that the share price will recover, however are they merging,or being taken over and by when ??? | alexwalia | |
04/3/2004 10:06 | amarone -badly expressed but more or less what I was saying in possibility (a)...there is the possibility of some major good news around the corner -from Malaysia.......perha | pariah | |
03/3/2004 18:49 | pariah - apologies but there is no LOGIC to the rise today. Firstly, the 'news' was a simple RNS which has to be reported due to the fact that Nomura is a book builder and secondly GMX is a high risk/high reward play however, even some of the punters who may have bought Marconi in 2000 would not have classed this as good news and bought in !! The LSE price for GMX is beginning to track the SGX price and not the other way around. GMX finished up 8% last night and LSE MM's followed. Like I said before, GMX is far more involved in the Far East markets due to their connections with the Maylasian Government and SGX, so perhaps the only 'logical' conclusion to today's rise is that they may know more than we do. Lets see what happens on the SGX tonight. Nil Pd - your thoughts please ?? IMHO,DYOR etc. AMARONE. | amarone | |
03/3/2004 17:30 | The logic of all this is (a) there is the possibility of some major good news around the corner or (b) there are people over reacting to the smallest bit of news that isn't "the end is nigh". From the look of the figures it's either sink or swim in the next 6 months -and they can only swim if things get a LOT better. | pariah | |
03/3/2004 10:52 | Todays breaking news..... Nomura buys 20000 and sells 100000, as far as I can see? At 13p thats only £13000 anyway. So why the excitement? Is it just that any news is better than none? Any enlightenment would be appreciated. | icetrader | |
03/3/2004 09:53 | Me 2 AMARONE. Good luck! | nil pd | |
03/3/2004 09:45 | Seem to be on real rollercoaster. Interesting that GMX were up some 8% on SGX last night. As the company has it's business interests firmly set in the Far East, I will be taking my lead from there and monitoring movements VERY closely. IMHO etc. AMARONE. | amarone | |
03/3/2004 09:38 | Could be soon, by the looks of today's move. | nil pd |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions